Pasar al contenido principal

Refine your results

Filtros
Buscar
Include spaces in matter number if applicable. Ex.: 182 3125
Fecha
Displaying 301 - 320 of 6901
HSR Informal Interpretations

2305004 Informal Interpretation

… 2305004 Informal Interpretation 2305004 Informal Interpretation From: Fetterman, Michelle … if the acquired entity is not its own UPE? … 2305004 Informal Interpretation …
Date
Rule
Item 6(a)
If this is a filing for the acquired person, you should list the acquired entity and all entities within it, not all the subsidiaries of the acquired person.
HSR Informal Interpretations

2304002 Informal Interpretation

… 2304002 Informal Interpretation 2304002 Informal Interpretation … We are hoping to assess whether a certain corporate transaction is subject to H.S.R. filing requirements. This would depend on how the transaction size is determined – in this case it could end up …
Date
Rule
801.10
If you can estimate the value of the earnout now, you have a determined acquisition price. If you can’t, you have to do a fair market value.
HSR Informal Interpretations

2304001 Informal Interpretation

… 2304001 Informal Interpretation 2304001 Informal Interpretation From: Shaffer, Kristin … Subject: FX and acquisition price Dear All: I have a transaction in which a European SPAC will be making a tender …
Date
Rule
801.10
Based upon the facts you have provided, we believe that this falls within 801.10(a)(1)(i). As a result, an FMV will not be necessary.
HSR Informal Interpretations

2303003 Informal Interpretation

… 2303003 Informal Interpretation 2303003 Informal Interpretation From: Whitehead, Nora … Am I reading the instructions correctly ? … 2303003 Informal Interpretation …
Date
Rule
Item 6(a)
Report all controlled US entities, regardless of whether they have sales in or into the US (subject to the $10MM threshold you reference below). For more guidance, see https://www.ftc.gov/enforcement...
Amicus Briefs

Sage Chemical, Inc. et al. v. Supernus Pharmaceuticals, Inc. et al.

… Pharmaceuticals, Inc. et al. The Federal Trade Commission filed an amicus brief with the U.S. District Court for the …
Date
Federal Court
District of Delaware
The Federal Trade Commission filed an amicus brief with the U.S. District Court for the District of Delaware in the case of Sage Chemical, Inc. et al. v. Supernus Pharmaceuticals, Inc. et al. The...
Cases and Proceedings

Dalal A. Akoury d/b/a AWAREmed, et al., U.S. v.

In March 2023, the FTC took action under the Opioid Addiction Recovery Fraud Prevention Act, suing Dr. Dalal A. Akoury and a set of companies she controls that operate as AWAREmed Health & Wellness Resource Center, a medical clinic, for making a wide range of false or unsupported claims for addiction treatment services, cancer treatment services, and the treatment of other serious conditions. The proposed order settling the Commission’s complaint bars Dr. Akoury and her AWAREmed clinic from making such unsupported claims and requires her to pay a $100,000 civil penalty.

 

Type of Action
Federal
Last Updated
FTC Matter/File Number
2123039
Docket Number
2:23-CV-00026
Case Status
Pending
Displaying 301 - 320 of 6901
Return to top